CDRT15P12

Across TCGA pan-cancer cohorts, CDRT15P12 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of CDRT15P12’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where CDRT15P12 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CDRT15P12 is over-expressed in tumor, although a few such as HNSC and THCA show the opposite, repressed pattern.

LUSC, LUAD, and HNSC are the cancer types where CDRT15P12 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDRT15P12 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Female	All	+0.935	<.001	8	view →
LUAD	All	III,IV	+0.488	.003	8	view →
HNSC	Male	II,III,IV	−0.298	.003	8	view →
THCA	Male	All	−0.368	<.001	7	view →
BRCA	Female	II,III,IV	−0.167	.006	4	view →
BLCA	All	All	+0.356	.036	2	view →
LIHC	Male	All	+0.235	.022	2	view →
KICH	Female	All	−0.223	.015	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

CDRT15P12–LUSC

Open the LUSC breakdown →